Pregnancy-associated osteoporosis following in vitro fertilization: A case report

被引:0
作者
Rahimi, Mehran [1 ]
Daneshvar, Sara [1 ]
Khabbazi, Alireza [1 ,2 ]
机构
[1] Tabriz Univ Med Sci, Connect Tissue Dis Res Ctr, Tabriz, Iran
[2] Tabriz Univ Med Sci, Imam Reza Hosp, Connect Tissue Dis Res Ctr, Flat 2, Tabriz, Iran
来源
CLINICAL CASE REPORTS | 2024年 / 12卷 / 03期
关键词
case report; gonadotropin-releasing hormone; in vitro fertilization (IVF); ovarian aging; pregnancy and lactation-associated osteoporosis; pregnancy-associated osteoporosis; POSTPARTUM OSTEOPOROSIS; HEPARIN; FRACTURES; IMPACT; RISK;
D O I
10.1002/ccr3.8702
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This case report illustrates that in vitro fertilization (IVF) may be a potential risk factor for pregnancy-associated osteoporosis (PAO), highlighting the need for awareness and monitoring of bone health in women undergoing IVF treatments. PAO is a rare disease resulting from an imbalance of calcium in the body during pregnancy and lactation and presenting with fragility fractures. PAO occurs in late pregnancy or early postpartum period. A 28-year-old woman who conceived through IVF experienced severe back pain 2 days after delivery. Magnetic resonance imaging of the spine showed wedge-shaped fractures of T9-T12 vertebrae. Bone mineral density (BMD) was low on dual-energy x-ray absorptiometry. The laboratory tests were within the normal range. Based on the clinical manifestations, osteoporotic spine fracture, results of BMD, and exclusion of other causes of osteoporosis, the patient was diagnosed with PAO. Considering the deleterious effect of treatment with gonadotropin-releasing hormone and repeated superovulation on bone, we hypothesized that IVF may be an etiological factor for PAO.
引用
收藏
页数:5
相关论文
共 16 条
  • [1] BUCHSBAUM HJ, 1970, OBSTET GYNECOL, V35, P613
  • [2] Postpartum osteoporosis associated with proximal tibial stress fracture
    Clemetson, IA
    Popp, A
    Lippuner, K
    Ballmer, F
    Anderson, SE
    [J]. SKELETAL RADIOLOGY, 2004, 33 (02) : 96 - 98
  • [3] Effects of heparin and low-molecular-weight heparins on bone mechanical properties in rats
    Folwarczna, J
    Janiec, W
    Sliwinski, L
    [J]. THROMBOSIS AND HAEMOSTASIS, 2004, 92 (05) : 940 - 946
  • [4] Prolonged low-molecular-weight heparin use during pregnancy and subsequent bone mineral density
    Galambosi, Paivi
    Hiilesmaa, Vilho
    Ulander, Veli-Matti
    Laitinena, Leena
    Tiitinen, Aila
    Kaaja, Risto
    [J]. THROMBOSIS RESEARCH, 2016, 143 : 122 - 126
  • [5] Gheita TA., 2018, INT J CLIN RHEUMATOL, V13, P134, DOI DOI 10.4172/1758-4272.1000177
  • [6] Pregnancy-associated osteoporosis: a case-control study
    Hadji, P.
    Boekhoff, J.
    Hahn, M.
    Hellmeyer, L.
    Hars, O.
    Kyvernitakis, I.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2017, 28 (04) : 1393 - 1399
  • [7] Effect of low molecular weight heparin (dalteparin) and fondaparinux (Arixtra®) on human osteoblasts in vitro
    Handschin, AE
    Trentz, OA
    Hoerstrup, SP
    Kock, HJ
    Wanner, GA
    Trentz, O
    [J]. BRITISH JOURNAL OF SURGERY, 2005, 92 (02) : 177 - 183
  • [8] Pregnancy and Lactation Associated Osteoporosis
    Hardcastle, Sarah A.
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2022, 110 (05) : 531 - 545
  • [9] Long-term magnesium sulfate tocolysis and maternal osteoporosis in a triplet pregnancy: A case report
    Levav, AL
    Chan, L
    Wapner, RJ
    [J]. AMERICAN JOURNAL OF PERINATOLOGY, 1998, 15 (01) : 43 - 46
  • [10] Postpartum osteoporosis and vertebral fractures in two patients treated with enoxaparin during pregnancy
    Ozdemir, D.
    Tam, A. A.
    Dirikoc, A.
    Ersoy, R.
    Cakir, B.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2015, 26 (01) : 415 - 418